Bacterial Outer Membrane Vesicles Could Transform Vaccine Formulations
Engineered Bacterial OMV. Credit: Kendrick B. Turner and Scott A. Walper, Bentham Science Publishers
Outer membrane vesicles, biological nanoparticles shed during normal growth by bacteria, have seen significant recent advances in engineering and are thus finding new utility as therapeutic and drug delivery agents. One specific research focus explored recently in the literature is the use of bacterial vesicles as adjuvants in vaccine formulations. Early success in this area has demonstrated protection against infection by a number of bacterial species in animal models by engineering vesicles to display species-specific antigens as cargo, either within the interior of the vesicles or displayed on the exterior vesicle surface.
In an effort to highlight recent advances in this field, this article explores recent and ongoing efforts to develop novel engineering methods aimed at providing new functionalities for bacterial vesicles as they apply to vaccine formulations. Specifically, emerging technologies for engineering these structures, including cargo loading and surface modification will be explored.
Bacterial vesicles show great promise as biologically-derived nanoparticles that could function as a platform technology in a variety of fields. With continued development of novel engineering tools, and an increased understanding in their biogenesis and biological fate in living systems there is significant potential to develop bacterial vesicles as tools for not only vaccine development but also for use in the delivery of therapeutic compounds to targeted cells.
This article has been republished from materials provided by Bentham Science. Note: material may have been edited for length and content. For further information, please contact the cited source.
Turner, K. B., & Walper, S. A. (2017). Bacterial Outer Membrane Vesicles: An Emerging Tool in Vaccine Development, as Adjuvants, and for Therapeutic Delivery. Drug Delivery Letters, 07. doi:10.2174/2210303107666170725163826
Molecules Brilliantly IlluminatedNews
Researchers want to use brilliant infrared light to study molecular disease markers in much greater detail. The team has developed a powerful femtosecond light source which emits at wavelengths between 1.6 and 10.2 micrometers. This instrument should make it possible to detect organic molecules present in extremely low concentrations in blood or aspirated air.
Liquid Cell Transmission Electron Microscopy Gives Nanoscale InsightsNews
Scientists and engineers dug into the mechanisms that degrade sample quality in liquid cell transmission electron microscopy (LC-TEM). They developed an LC-TEM device that uses multiple windows and patterned features to explore the impacts of high-energy electron bombardment on nanoparticles and sensitive biological samples.READ MORE
Compound Offers Pain-relief of Opioids Without Addictive PropertiesNews
Researchers have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.READ MORE